ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Menopause Hormonal Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0U13834
Home | Market Reports | Health| Reproductive Health
Global Menopause Hormonal Treatment Market Research Report 2023
BUY CHAPTERS

Global Menopause Hormonal Treatment Market Research Report 2025

Code: QYRE-Auto-0U13834
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Pure Encapsulations, Inc.
Bayer
Theramex
AbbVie
Novo Nordisk
Emcure Pharmaceuticals
Allergan plc
Pfizer Inc
Merck
Cipla Ltd
Eli Lilly and Company
Teva Pharmaceutical Industries

Menopause Hormonal Treatment Market Size

The global market for Menopause Hormonal Treatment was valued at US$ 16160 million in the year 2024 and is projected to reach a revised size of US$ 23080 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Menopause Hormonal Treatment Market

Menopause Hormonal Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Menopause Hormonal Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopause Hormonal Treatment.
The Menopause Hormonal Treatment market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Menopause Hormonal Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menopause Hormonal Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Menopause Hormonal Treatment Market Report

Report Metric Details
Report Name Menopause Hormonal Treatment Market
Accounted market size in year US$ 16160 million
Forecasted market size in 2031 US$ 23080 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Table
  • Patch
  • Spray
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla, Teva Pharmaceutical Industries, Pure Encapsulations, Inc., Bayer, Theramex, AbbVie
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Menopause Hormonal Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Menopause Hormonal Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Menopause Hormonal Treatment Market growing?

Ans: The Menopause Hormonal Treatment Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Menopause Hormonal Treatment Market size in 2031?

Ans: The Menopause Hormonal Treatment Market size in 2031 will be US$ 23080 million.

Who are the main players in the Menopause Hormonal Treatment Market report?

Ans: The main players in the Menopause Hormonal Treatment Market are Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla, Teva Pharmaceutical Industries, Pure Encapsulations, Inc., Bayer, Theramex, AbbVie

What are the Application segmentation covered in the Menopause Hormonal Treatment Market report?

Ans: The Applications covered in the Menopause Hormonal Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Menopause Hormonal Treatment Market report?

Ans: The Types covered in the Menopause Hormonal Treatment Market report are Table, Patch, Spray, Others

Recommended Reports

Women's Health Drugs

Hormone Related Treatment

Female Related Therapy

1 Menopause Hormonal Treatment Market Overview
1.1 Product Definition
1.2 Menopause Hormonal Treatment by Type
1.2.1 Global Menopause Hormonal Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Table
1.2.3 Patch
1.2.4 Spray
1.2.5 Others
1.3 Menopause Hormonal Treatment by Application
1.3.1 Global Menopause Hormonal Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Menopause Hormonal Treatment Market Size Estimates and Forecasts
1.4.1 Global Menopause Hormonal Treatment Revenue 2020-2031
1.4.2 Global Menopause Hormonal Treatment Sales 2020-2031
1.4.3 Global Menopause Hormonal Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Menopause Hormonal Treatment Market Competition by Manufacturers
2.1 Global Menopause Hormonal Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Menopause Hormonal Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Menopause Hormonal Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Menopause Hormonal Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Menopause Hormonal Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menopause Hormonal Treatment, Product Type & Application
2.7 Global Key Manufacturers of Menopause Hormonal Treatment, Date of Enter into This Industry
2.8 Global Menopause Hormonal Treatment Market Competitive Situation and Trends
2.8.1 Global Menopause Hormonal Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Menopause Hormonal Treatment Players Market Share by Revenue
2.8.3 Global Menopause Hormonal Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Menopause Hormonal Treatment Market Scenario by Region
3.1 Global Menopause Hormonal Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Menopause Hormonal Treatment Sales by Region: 2020-2031
3.2.1 Global Menopause Hormonal Treatment Sales by Region: 2020-2025
3.2.2 Global Menopause Hormonal Treatment Sales by Region: 2026-2031
3.3 Global Menopause Hormonal Treatment Revenue by Region: 2020-2031
3.3.1 Global Menopause Hormonal Treatment Revenue by Region: 2020-2025
3.3.2 Global Menopause Hormonal Treatment Revenue by Region: 2026-2031
3.4 North America Menopause Hormonal Treatment Market Facts & Figures by Country
3.4.1 North America Menopause Hormonal Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Menopause Hormonal Treatment Sales by Country (2020-2031)
3.4.3 North America Menopause Hormonal Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Menopause Hormonal Treatment Market Facts & Figures by Country
3.5.1 Europe Menopause Hormonal Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Menopause Hormonal Treatment Sales by Country (2020-2031)
3.5.3 Europe Menopause Hormonal Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menopause Hormonal Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Menopause Hormonal Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Menopause Hormonal Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Menopause Hormonal Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Menopause Hormonal Treatment Market Facts & Figures by Country
3.7.1 Latin America Menopause Hormonal Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Menopause Hormonal Treatment Sales by Country (2020-2031)
3.7.3 Latin America Menopause Hormonal Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menopause Hormonal Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Menopause Hormonal Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Menopause Hormonal Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menopause Hormonal Treatment Sales by Type (2020-2031)
4.1.1 Global Menopause Hormonal Treatment Sales by Type (2020-2025)
4.1.2 Global Menopause Hormonal Treatment Sales by Type (2026-2031)
4.1.3 Global Menopause Hormonal Treatment Sales Market Share by Type (2020-2031)
4.2 Global Menopause Hormonal Treatment Revenue by Type (2020-2031)
4.2.1 Global Menopause Hormonal Treatment Revenue by Type (2020-2025)
4.2.2 Global Menopause Hormonal Treatment Revenue by Type (2026-2031)
4.2.3 Global Menopause Hormonal Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Menopause Hormonal Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Menopause Hormonal Treatment Sales by Application (2020-2031)
5.1.1 Global Menopause Hormonal Treatment Sales by Application (2020-2025)
5.1.2 Global Menopause Hormonal Treatment Sales by Application (2026-2031)
5.1.3 Global Menopause Hormonal Treatment Sales Market Share by Application (2020-2031)
5.2 Global Menopause Hormonal Treatment Revenue by Application (2020-2031)
5.2.1 Global Menopause Hormonal Treatment Revenue by Application (2020-2025)
5.2.2 Global Menopause Hormonal Treatment Revenue by Application (2026-2031)
5.2.3 Global Menopause Hormonal Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Menopause Hormonal Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Menopause Hormonal Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Menopause Hormonal Treatment Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novo Nordisk Menopause Hormonal Treatment Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Menopause Hormonal Treatment Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Company Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Allergan Menopause Hormonal Treatment Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Emcure Pharmaceuticals
6.6.1 Emcure Pharmaceuticals Company Information
6.6.2 Emcure Pharmaceuticals Description and Business Overview
6.6.3 Emcure Pharmaceuticals Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio
6.6.5 Emcure Pharmaceuticals Recent Developments/Updates
6.7 Eli Lilly And Company
6.7.1 Eli Lilly And Company Company Information
6.7.2 Eli Lilly And Company Description and Business Overview
6.7.3 Eli Lilly And Company Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio
6.7.5 Eli Lilly And Company Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Company Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cipla Menopause Hormonal Treatment Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Teva Pharmaceutical Industries
6.9.1 Teva Pharmaceutical Industries Company Information
6.9.2 Teva Pharmaceutical Industries Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio
6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.10 Pure Encapsulations, Inc.
6.10.1 Pure Encapsulations, Inc. Company Information
6.10.2 Pure Encapsulations, Inc. Description and Business Overview
6.10.3 Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio
6.10.5 Pure Encapsulations, Inc. Recent Developments/Updates
6.11 Bayer
6.11.1 Bayer Company Information
6.11.2 Bayer Description and Business Overview
6.11.3 Bayer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bayer Menopause Hormonal Treatment Product Portfolio
6.11.5 Bayer Recent Developments/Updates
6.12 Theramex
6.12.1 Theramex Company Information
6.12.2 Theramex Description and Business Overview
6.12.3 Theramex Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Theramex Menopause Hormonal Treatment Product Portfolio
6.12.5 Theramex Recent Developments/Updates
6.13 AbbVie
6.13.1 AbbVie Company Information
6.13.2 AbbVie Description and Business Overview
6.13.3 AbbVie Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AbbVie Menopause Hormonal Treatment Product Portfolio
6.13.5 AbbVie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menopause Hormonal Treatment Industry Chain Analysis
7.2 Menopause Hormonal Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menopause Hormonal Treatment Production Mode & Process Analysis
7.4 Menopause Hormonal Treatment Sales and Marketing
7.4.1 Menopause Hormonal Treatment Sales Channels
7.4.2 Menopause Hormonal Treatment Distributors
7.5 Menopause Hormonal Treatment Customer Analysis
8 Menopause Hormonal Treatment Market Dynamics
8.1 Menopause Hormonal Treatment Industry Trends
8.2 Menopause Hormonal Treatment Market Drivers
8.3 Menopause Hormonal Treatment Market Challenges
8.4 Menopause Hormonal Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Pure Encapsulations, Inc.
Bayer
Theramex
AbbVie
Novo Nordisk
Emcure Pharmaceuticals
Allergan plc
Pfizer Inc
Merck
Cipla Ltd
Eli Lilly and Company
Teva Pharmaceutical Industries
List of Tables
 Table 1. Global Menopause Hormonal Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Menopause Hormonal Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Menopause Hormonal Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Menopause Hormonal Treatment Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Menopause Hormonal Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Menopause Hormonal Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Menopause Hormonal Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Menopause Hormonal Treatment Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Menopause Hormonal Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Menopause Hormonal Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Menopause Hormonal Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Menopause Hormonal Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Menopause Hormonal Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Hormonal Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Menopause Hormonal Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Menopause Hormonal Treatment Sales by Region (2020-2025) & (Tons)
 Table 18. Global Menopause Hormonal Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Menopause Hormonal Treatment Sales by Region (2026-2031) & (Tons)
 Table 20. Global Menopause Hormonal Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Menopause Hormonal Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Menopause Hormonal Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Menopause Hormonal Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Menopause Hormonal Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Menopause Hormonal Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Menopause Hormonal Treatment Sales by Country (2020-2025) & (Tons)
 Table 27. North America Menopause Hormonal Treatment Sales by Country (2026-2031) & (Tons)
 Table 28. North America Menopause Hormonal Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Menopause Hormonal Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Menopause Hormonal Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Menopause Hormonal Treatment Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Menopause Hormonal Treatment Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Menopause Hormonal Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Menopause Hormonal Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Menopause Hormonal Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Menopause Hormonal Treatment Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Menopause Hormonal Treatment Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Menopause Hormonal Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Menopause Hormonal Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Menopause Hormonal Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Menopause Hormonal Treatment Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Menopause Hormonal Treatment Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Menopause Hormonal Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Menopause Hormonal Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Menopause Hormonal Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Menopause Hormonal Treatment Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Menopause Hormonal Treatment Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Menopause Hormonal Treatment Sales (Tons) by Type (2020-2025)
 Table 51. Global Menopause Hormonal Treatment Sales (Tons) by Type (2026-2031)
 Table 52. Global Menopause Hormonal Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Menopause Hormonal Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Menopause Hormonal Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Menopause Hormonal Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Menopause Hormonal Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Menopause Hormonal Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Menopause Hormonal Treatment Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Menopause Hormonal Treatment Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Menopause Hormonal Treatment Sales (Tons) by Application (2020-2025)
 Table 61. Global Menopause Hormonal Treatment Sales (Tons) by Application (2026-2031)
 Table 62. Global Menopause Hormonal Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Menopause Hormonal Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Menopause Hormonal Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Menopause Hormonal Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Menopause Hormonal Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Menopause Hormonal Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Menopause Hormonal Treatment Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Menopause Hormonal Treatment Price (US$/Ton) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Merck Menopause Hormonal Treatment Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Novartis Menopause Hormonal Treatment Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Novo Nordisk Company Information
 Table 81. Novo Nordisk Description and Business Overview
 Table 82. Novo Nordisk Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Novo Nordisk Menopause Hormonal Treatment Product
 Table 84. Novo Nordisk Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Pfizer Menopause Hormonal Treatment Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Allergan Company Information
 Table 91. Allergan Description and Business Overview
 Table 92. Allergan Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Allergan Menopause Hormonal Treatment Product
 Table 94. Allergan Recent Developments/Updates
 Table 95. Emcure Pharmaceuticals Company Information
 Table 96. Emcure Pharmaceuticals Description and Business Overview
 Table 97. Emcure Pharmaceuticals Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Emcure Pharmaceuticals Menopause Hormonal Treatment Product
 Table 99. Emcure Pharmaceuticals Recent Developments/Updates
 Table 100. Eli Lilly And Company Company Information
 Table 101. Eli Lilly And Company Description and Business Overview
 Table 102. Eli Lilly And Company Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Eli Lilly And Company Menopause Hormonal Treatment Product
 Table 104. Eli Lilly And Company Recent Developments/Updates
 Table 105. Cipla Company Information
 Table 106. Cipla Description and Business Overview
 Table 107. Cipla Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Cipla Menopause Hormonal Treatment Product
 Table 109. Cipla Recent Developments/Updates
 Table 110. Teva Pharmaceutical Industries Company Information
 Table 111. Teva Pharmaceutical Industries Description and Business Overview
 Table 112. Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Teva Pharmaceutical Industries Menopause Hormonal Treatment Product
 Table 114. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 115. Pure Encapsulations, Inc. Company Information
 Table 116. Pure Encapsulations, Inc. Description and Business Overview
 Table 117. Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Pure Encapsulations, Inc. Menopause Hormonal Treatment Product
 Table 119. Pure Encapsulations, Inc. Recent Developments/Updates
 Table 120. Bayer Company Information
 Table 121. Bayer Description and Business Overview
 Table 122. Bayer Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Bayer Menopause Hormonal Treatment Product
 Table 124. Bayer Recent Developments/Updates
 Table 125. Theramex Company Information
 Table 126. Theramex Description and Business Overview
 Table 127. Theramex Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Theramex Menopause Hormonal Treatment Product
 Table 129. Theramex Recent Developments/Updates
 Table 130. AbbVie Company Information
 Table 131. AbbVie Description and Business Overview
 Table 132. AbbVie Menopause Hormonal Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. AbbVie Menopause Hormonal Treatment Product
 Table 134. AbbVie Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Menopause Hormonal Treatment Distributors List
 Table 138. Menopause Hormonal Treatment Customers List
 Table 139. Menopause Hormonal Treatment Market Trends
 Table 140. Menopause Hormonal Treatment Market Drivers
 Table 141. Menopause Hormonal Treatment Market Challenges
 Table 142. Menopause Hormonal Treatment Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Menopause Hormonal Treatment
 Figure 2. Global Menopause Hormonal Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Menopause Hormonal Treatment Market Share by Type: 2024 & 2031
 Figure 4. Table Product Picture
 Figure 5. Patch Product Picture
 Figure 6. Spray Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Menopause Hormonal Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Menopause Hormonal Treatment Market Share by Application: 2024 & 2031
 Figure 10. Hospital Pharmacies
 Figure 11. Retail Pharmacies
 Figure 12. Online Pharmacies
 Figure 13. Global Menopause Hormonal Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Menopause Hormonal Treatment Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Menopause Hormonal Treatment Sales (2020-2031) & (Tons)
 Figure 16. Global Menopause Hormonal Treatment Average Price (US$/Ton) & (2020-2031)
 Figure 17. Menopause Hormonal Treatment Report Years Considered
 Figure 18. Menopause Hormonal Treatment Sales Share by Manufacturers in 2024
 Figure 19. Global Menopause Hormonal Treatment Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Menopause Hormonal Treatment Players: Market Share by Revenue in Menopause Hormonal Treatment in 2024
 Figure 21. Menopause Hormonal Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Menopause Hormonal Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Menopause Hormonal Treatment Sales Market Share by Country (2020-2031)
 Figure 24. North America Menopause Hormonal Treatment Revenue Market Share by Country (2020-2031)
 Figure 25. United States Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Menopause Hormonal Treatment Sales Market Share by Country (2020-2031)
 Figure 28. Europe Menopause Hormonal Treatment Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Menopause Hormonal Treatment Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Menopause Hormonal Treatment Revenue Market Share by Region (2020-2031)
 Figure 36. China Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Menopause Hormonal Treatment Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Menopause Hormonal Treatment Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Menopause Hormonal Treatment Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Menopause Hormonal Treatment Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Menopause Hormonal Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Menopause Hormonal Treatment by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Menopause Hormonal Treatment by Type (2020-2031)
 Figure 55. Global Menopause Hormonal Treatment Price (US$/Ton) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Menopause Hormonal Treatment by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Menopause Hormonal Treatment by Application (2020-2031)
 Figure 58. Global Menopause Hormonal Treatment Price (US$/Ton) by Application (2020-2031)
 Figure 59. Menopause Hormonal Treatment Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Male Menopause Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menopausal Hot Flashes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gynecological Cancers Drug Market Research Report 2025
Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2024
Global Drugs for Hormonal Replacement Therapy Market Research Report 2024
Global Reproductive and Fertility Diagnosis Market Research Report 2025
Global Obstetrics and Gynecology Drugs Market Research Report 2025
Global Menopausal Hot Flashes Medicines Market Research Report 2025
Hair Loss Treatment for Man Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormonal Infertility Treatment Market Research Report 2022
Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Fertility Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions